AGP Picks
View all

Cartilage degeneration market seen reaching $17.72 billion by 2030

Nov. 10, 2026
Cartilage degeneration market seen reaching $17.72 billion by 2030
By AI, Created 17:00 UTC, Nov 10, 2026, AGP -

The cartilage degeneration market is projected to grow from $13.4 billion in 2025 to $17.72 billion by 2030, according to The Business Research Company. Rising obesity, osteoarthritis cases, and demand for regenerative therapies are expected to drive the market, with North America leading now and Asia-Pacific growing fastest.

Why it matters: - Cartilage degeneration affects joint function, mobility and quality of life, making treatments and restoration technologies a growing healthcare priority. - The market’s projected expansion signals stronger demand for orthopedic procedures, biologic therapies and regenerative medicine. - Rising obesity rates are adding pressure to the joint-care market by increasing cartilage damage risk.

What happened: - The Business Research Company released its Cartilage Degeneration Global Market Report 2026, covering market size, trends and forecasts for 2026-2035. - The report estimates the market at $13.4 billion in 2025 and $14.08 billion in 2026. - The market is forecast to reach $17.72 billion by 2030, implying a 5.9% CAGR over the forecast period. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period.

The details: - Cartilage degeneration is the gradual breakdown of cartilage, the smooth connective tissue that cushions joints and reduces friction between bones. - Cartilage deterioration can cause joint pain, stiffness and reduced mobility. - Growth in the market has been supported by more osteoarthritis cases, more orthopedic surgeries, an aging population, improvements in surgical technology and wider use of joint preservation treatments. - Future growth is expected to come from investment in regenerative medicine, demand for biologic cartilage repair solutions, expansion of stem cell therapies, more personalized orthopedic care and broader use of cartilage restoration procedures. - Key trends include cell-based repair techniques, minimally invasive surgery, regenerative medicine approaches, advanced diagnostic imaging and a stronger focus on long-term joint health preservation. - Obesity is a major growth factor because excess body fat increases compressive forces on cartilage and can trigger inflammatory responses. - Obesity also contributes to abnormal load distribution, joint misalignment and muscle weakness in the knee. - NHS Digital reported in November 2024 that obesity among UK children ages 4 to 5 rose from 9.2% in 2022/23 to 9.6% in 2023/24. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The 2026 report package includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, plus updated graphics and tables. - The report offers a free sample and a full version through the company’s website, including the sample request page and the full market report.

Between the lines: - The forecast points to a market shifting from basic joint repair toward more advanced, biologics-led treatment models. - The obesity link suggests demand growth is being reinforced by broader public health trends, not just by aging populations. - North America’s lead likely reflects stronger access to advanced care, while Asia-Pacific’s growth suggests catching-up demand and expanding treatment access.

What’s next: - The market is expected to keep growing as regenerative medicine, stem cell therapies and personalized orthopedic care gain broader use. - Continued obesity growth and aging populations are likely to support demand for cartilage repair and joint preservation treatments. - The Business Research Company is positioning the 2026 report as an updated planning tool for market forecasting and strategy work.

The bottom line: - Cartilage degeneration is moving into a steady-growth phase, with the market expected to climb to $17.72 billion by 2030 on the back of rising joint disease, obesity and next-generation treatment demand.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

UK Post Observer

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

UK Post Observer

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.